Tenosynovial giant cell tumor, diffuse type
MONDO:0024686A locally aggressive, diffusely infiltrating tumor, arising in the tendon sheath. It is composed of synovial-like mononuclear cells, hemosiderin-laden macrophages, foam cells, and inflammatory cells. Multinucleated osteoclast-like giant cells are usually present, although in a minority of cases they may be absent or rare. It predominantly affects young adults. Symptoms include joint swelling, pain, and joint effusion.
Also known as: TGCT, TSGCT, Tenosynovial Giant Cell Tumor, diffuse giant cell neoplasm of Tenosynovium, diffuse giant cell neoplasm of tendon sheath, diffuse giant cell neoplasm of the Tenosynovium, diffuse giant cell tumor of Tenosynovium, diffuse giant cell tumor of tendon sheath
1468 clinical trials for this condition and its sub-types, 9 tagged with Tenosynovial giant cell tumor, diffuse type itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Personalized maintenance therapy: a smarter way to treat advanced cancer?
Disease control Recruiting nowThis phase II trial is testing whether continuing targeted therapy or immunotherapy based on a tumor's molecular profile can benefit patients with advanced solid tumors that have stopped responding to prior treatment. After an initial treatment period, patients whose disease is s…
Phase 2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Joint tissue study aims to personalize rare disease treatment
Knowledge-focused Recruiting nowThis study looks at whether analyzing synovial tissue can help doctors better manage pigmented villonodular synovitis (PVNS), a rare joint disease that causes pain and joint damage. Researchers will collect tissue samples from 30 patients through biopsy or surgery to assess quali…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC